cladribine,venetoclax,fludarabine,cytarabine,idarubicin
Bayer,merck,abbvie,roche
['fludarabine', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'cladribine']
flag-ida + ven in rr aml. response based on eln criteria: 85% (fav), 75% (intermediate), 41% (adverse). 70% of responders received sct. unfortunately no benefit in tp53 mut pts. may need to pivot to cladribine given flu shortages. #ash22 
Assistant Professor at UNC Eshelman School of Pharmacy. #adherence, #leukemia, #globalhealth, #access, #impsci, #equity